Matches in Wikidata for { <http://www.wikidata.org/entity/Q90809274> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q90809274 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90809274 description "bài báo khoa học" @default.
- Q90809274 description "im März 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90809274 description "scientific article published on 30 March 2020" @default.
- Q90809274 description "wetenschappelijk artikel" @default.
- Q90809274 description "наукова стаття, опублікована 30 березня 2020" @default.
- Q90809274 name "Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)" @default.
- Q90809274 name "Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)" @default.
- Q90809274 type Item @default.
- Q90809274 label "Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)" @default.
- Q90809274 label "Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)" @default.
- Q90809274 prefLabel "Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)" @default.
- Q90809274 prefLabel "Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)" @default.
- Q90809274 P1433 Q90809274-EEE230D9-2BF0-412A-A7C0-36EB9FA3923B @default.
- Q90809274 P1476 Q90809274-87F92073-9DE5-4BA8-A8E3-5EBF42965998 @default.
- Q90809274 P2093 Q90809274-42765066-C937-4930-B971-D82927083F7C @default.
- Q90809274 P2093 Q90809274-F17558EE-91A8-41A8-9DE1-990DB609EB4B @default.
- Q90809274 P275 Q90809274-43a2dc60-2a8b-47b7-8fd7-5d6f62337a59 @default.
- Q90809274 P31 Q90809274-1F048A03-8885-4B63-914D-6CAA8451A72F @default.
- Q90809274 P356 Q90809274-07D11D9E-D457-4187-A661-F936A816EB57 @default.
- Q90809274 P433 Q90809274-06D174B2-F34E-49BF-AF83-E88BD764B6C7 @default.
- Q90809274 P478 Q90809274-F94FEAFA-2170-4A19-9334-34892D4C1282 @default.
- Q90809274 P50 Q90809274-0B1291AD-8FB7-4FE6-8F86-D13422B6FA5B @default.
- Q90809274 P50 Q90809274-14F847C7-04A1-4238-8FA3-8401170D417C @default.
- Q90809274 P50 Q90809274-561FA64B-9A54-4002-8B3D-9201C00CA580 @default.
- Q90809274 P577 Q90809274-79B02A72-F76C-49AD-B897-ED71D24DAE7F @default.
- Q90809274 P6216 Q90809274-2d81e97b-a346-45e1-ad33-475eb2bc17f7 @default.
- Q90809274 P698 Q90809274-1D6451E4-04A7-499D-A74E-0F4BB28A7EBA @default.
- Q90809274 P921 Q90809274-326A83B4-209E-4BEE-B92F-17061EA7446E @default.
- Q90809274 P921 Q90809274-B9F94D33-60C0-4568-8AD9-FE02C2D73B7F @default.
- Q90809274 P932 Q90809274-D2E8ACC6-566A-4BA5-B93B-E1B277E86E72 @default.
- Q90809274 P356 CANCERS12040826 @default.
- Q90809274 P698 32235443 @default.
- Q90809274 P1433 Q27722963 @default.
- Q90809274 P1476 "Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)" @default.
- Q90809274 P2093 "Francesco Salvo" @default.
- Q90809274 P2093 "Louis Letinier" @default.
- Q90809274 P275 Q20007257 @default.
- Q90809274 P31 Q13442814 @default.
- Q90809274 P356 "10.3390/CANCERS12040826" @default.
- Q90809274 P433 "4" @default.
- Q90809274 P478 "12" @default.
- Q90809274 P50 Q38361949 @default.
- Q90809274 P50 Q38361970 @default.
- Q90809274 P50 Q90809264 @default.
- Q90809274 P577 "2020-03-30T00:00:00Z" @default.
- Q90809274 P6216 Q50423863 @default.
- Q90809274 P698 "32235443" @default.
- Q90809274 P921 Q11688946 @default.
- Q90809274 P921 Q729735 @default.
- Q90809274 P932 "7226142" @default.